Prevalence of Sickle Cell Trait and Reliability of Self-Reported Status among Expectant Parents in Nigeria: Implications for Targeted Newborn Scree... - PubMed - NCBI

Prevalence of Sickle Cell Trait and Reliability of Self-Reported Status among Expectant Parents in Nigeria: Implications for Targeted Newborn Scree... - PubMed - NCBI

Public Health Genomics. 2016 Sep 10;19(5). [Epub ahead of print]

Prevalence of Sickle Cell Trait and Reliability of Self-Reported Status among Expectant Parents in Nigeria: Implications for Targeted Newborn Screening.

Burnham-Marusich AR, Ezeanolue CO, Obiefune MC, Yang W, Osuji A, Ogidi AG, Hunt AT, Patel D, Ezeanolue EE.

Abstract

BACKGROUND/AIMS:

Sickle cell disease (SCD) is a life-threatening, autosomal recessive blood disorder prevalent in sub-Saharan Africa. We identified the prevalence of sickle cell trait (SCT) among pregnant women and their male partners in Enugu State, Nigeria, and determined the accuracy of self-reported sickle cell status and its reliability for identifying high-risk newborns for targeted screening.

METHODS:

We conducted a nested cohort study of expectant parents enrolled in the Healthy Beginning Initiative (HBI). The HBI is a cluster-randomized trial of a congregation-based approach designed to increase HIV testing. Participants completed a survey regarding self-awareness of their sickle cell genotype and consented to genotype screening by cellulose acetate electrophoresis.

RESULTS:

SCT prevalence (HbAS) was 22% (746/3,371). Only 50% of participants provided an accurate self-report. Self-report accuracy was significantly different (p < 0.0001) between individuals who reported having SCT or SCD (61% accuracy) versus those who reported not having SCT or SCD (86% accuracy). Demographic variables including gender, age, household size, employment, education, and home location were significantly associated with providing an accurate self-report.

CONCLUSIONS:

Low numbers of accurate parental self-reports, coupled with a high SCT prevalence in Nigeria, could limit the efficacy of targeted newborn screening. However, our data indicate that it is feasible to integrate sickle cell screening for pregnant women with existing, community-based health care programs developed by the President's Emergency Plan for AIDS Relief (PEPFAR), such as the HBI. Expanding screening programs could enable the development of targeted newborn screening based on maternal genotype that could identify all newborns with SCD in resource-limited settings.

© 2016 The Author(s) Published by S. Karger AG, Basel.

PMID:

 

27614873

 

DOI:

 

10.1159/000448914

[PubMed - as supplied by publisher] 

Free full text

Public Health Genomics Knowledge Base (v1.2)

SICKLE CELL DISEASE

Last Updated: Sep 15, 2016

• Prevalence of Sickle Cell Trait and Reliability of Self-Reported Status among Expectant Parents in Nigeria: Implications for Targeted Newborn Screening.
  Burnham-Marusich Amanda R et al. Public health genomics 2016 Sep 19(5)
• Public Health Research, Epidemiology, and Surveillance for Hemoglobinopathies (PHRESH) 
• Sickle Cell Awareness 
• Sickle Cell Data Collection (SCDC) Program 
• Gene therapy for sickle cell moves closer as scientists clear unexpected obstacle
  StatNews, September 7, 2016
• A genetic variation associated with plasma erythropoietin and a non-coding transcript of PRKAR1A in Sickle Cell Disease.
  Zhang Xu, et al. Human molecular genetics 2016 8
• Sickle cell disease in western Sudan: genetic epidemiology and predictors of knowledge attitude and practices.
  Daak Ahmed A et al. Tropical medicine & international health : TM & IH 2016 May 21(5) 642-53
• Progressing Preemptive Genotyping of CYP2C19 Allelic Variants for Sickle Cell Disease Patients.
  Jaja Cheedy, et al. Genetic testing and molecular biomarkers 2016 8
• Getting out of a sticky situation
  ML Hulbert, Science Trans Med, August 10, 2016
• Newborn screening and prophylactic interventions for sickle cell disease in 47 countries in sub-Saharan Africa: a cost-effectiveness analysis.
  Kuznik Andreas et al. BMC health services research 2016 16(1) 304
• Physicians' Perception of Sickle-cell Disease Pain.
  Lucchesi Fátima et al. Journal of the National Medical Association 2016 May 108(2) 113-118
• Pharmacogenetics for Safe Codeine Use in Sickle Cell Disease.
  Gammal Roseann S et al. Pediatrics 2016 Jun
• Sickle Cell Trait Screening of Collegiate Athletes: Ethical Reasons for Program Reform.
  Ferrari Rosalie et al. Journal of genetic counseling 2015 Dec 24(6) 873-7
• Significant prevalence of sickle cell disease in Southwest Germany: results from a birth cohort study indicate the necessity for newborn screening.
  Kunz Joachim B et al. Annals of hematology 2016 Feb 95(3) 397-402
• Developing a Unified Approach for Sickle Cell Disease
  Am J Prev Pemd, July 2016

• CDC Information (12)
• CDC-Authored Pub (16)

• Human (20)
• Pathogen (1)

• Human (268)
• Pathogen (0)

• Human (54)
• Pathogen (0)

• Guidelines (2)
• Tier Table (0)
• Synthesis (5)

• Huamn (8)
• Pathogen (0)

Relevant Resources

• Cancer Genomics and Epidemiology Navigator (CGEN)
• Genetics and Genomics Competencies Center (G2C2)
• NIH Genetic Testing Registry
• NIH MedGen Database
• Online Mendelian Inheritance in Man (OMIM)
• PharmGKB